Experimental Drug Shows Benefits Against Melanoma in Early Study

A new drug called lambrolizumab appears to improve outcomes in patients with advanced melanoma, according to the results of a phase 1 trial.

http://news.health.com/2013/06/02/experimental-drug-shows-benefits-against-melanoma-in-early-study/